COMMUNIQUÉS West-GlobeNewswire

-
Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates
13/05/2025 -
New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)
13/05/2025 -
Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
13/05/2025 -
Best HGH for Men to Buy Online: Natural HGH for Sale for Men - Legal Human Growth Hormone for Muscle Growth and Fat Loss - CrazyBulk
13/05/2025 -
Best Creatine For Women: Top Creatine Supplements For Muscle Growth & Female Athletes
13/05/2025 -
Neo Medical and POCUS Certification Academy Launch Forward-Thinking Device and Education Bundle
13/05/2025 -
Alumis Stockholders Approve Merger with ACELYRIN
13/05/2025 -
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
13/05/2025 -
Comprehensive Healthcare Expands Same-Day Access to Include Substance Use Treatment
13/05/2025 -
Best Appetite Suppressant 2025: Top OTC Weight Loss Pills To Control Cravings For Men & Women - Wolfson Brands (UK) Limited
13/05/2025 -
Media Advisory/OHC - Day of Action at Ontario Legislature to Stop Hospital Closures
13/05/2025 -
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
13/05/2025 -
AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
13/05/2025 -
Best Kratom for Pain: Happy Go Leafy’s Strains for Chronic Pain Relief and Natural Wellness
13/05/2025 -
ARC Fertility Wins 2025 MedTech Breakthrough Award for Best Reproductive Health Technology Solution
13/05/2025 -
Applied Pharmaceutical Innovation Appoints Dr. Launa Aspeslet as Chief Translational Officer to Accelerate Life Sciences Commercialization in Canada
13/05/2025 -
Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
13/05/2025 -
Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
13/05/2025 -
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
13/05/2025
Pages